Breast implant-associated anaplastic large-cell lymphoma (BIAALCL) is a rare form of non-Hodgkin T-cell lymphoma associated with breast reconstruction post-mastectomy or cosmetic-additive mammoplasty. The increasing use of implants for cosmetic purposes is expected to lead to an increase in BIA-ALCL cases. This study investigated the main characteristics of the disease and the factors predicting BIA-ALCL onset in patients with and without an implant replacement.
Vittorietti, M., Mazzola, S., Costantino, C., De Bella, D.D., Fruscione, S., Bonaccorso, N., et al. (2023). Implant replacement and anaplastic large cell lymphoma associated with breast implants: a quantitative analysis. FRONTIERS IN ONCOLOGY, 13 [10.3389/fonc.2023.1202733].
Implant replacement and anaplastic large cell lymphoma associated with breast implants: a quantitative analysis
Vittorietti, Martina;Mazzola, Sergio;Costantino, Claudio;De Bella, Daniele Domenico;Fruscione, Santo;Bonaccorso, Nicole;Sciortino, Martina;Costanza, Davide;Belluzzo, Miriam;Savatteri, Alessandra;Tramuto, Fabio;Immordino, Palmira;Vitale, Francesco;Mazzucco, Walter
2023-10-19
Abstract
Breast implant-associated anaplastic large-cell lymphoma (BIAALCL) is a rare form of non-Hodgkin T-cell lymphoma associated with breast reconstruction post-mastectomy or cosmetic-additive mammoplasty. The increasing use of implants for cosmetic purposes is expected to lead to an increase in BIA-ALCL cases. This study investigated the main characteristics of the disease and the factors predicting BIA-ALCL onset in patients with and without an implant replacement.
| File | Dimensione | Formato | |
|---|---|---|---|
|
fonc-13-1202733.pdf
accesso aperto
Tipologia:
Versione Editoriale
Dimensione
874.19 kB
Formato
Adobe PDF
|
874.19 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
